Delivery Order SPE2DB20D1109-SPE2DB23FP70K
Award Date
8/9/23
Potential Completion Date
8/30/23
Potential Value
$453
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $453,170 firm fixed price delivery order to Amerisourcebergen Drug Corporation for RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML. This order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DOD and other federal customers. Amerisourcebergen will deliver the specified medication from its facility in Conshohocken, Pennsylvania by October 18, 2023 to support DLA's mission to provide medical supplies and...
The Defense Logistics Agency awarded a $906.36 firm fixed price delivery order to Amerisourcebergen Drug Corporation for RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML. The prime contractor will deliver the specified pharmaceutical product to a location in Conshohocken, Pennsylvania by August 24, 2023 in support of DLA programs. No major subcontractors or set aside designations were indicated. DLA manages the global supply chain for the United States Department of Defense, procuring critical medical...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML. The contract has a firm fixed price of $1,377.03 and an ultimate completion date of August 19, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,434.00, is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of March 7, 2025. The contract is for the supply of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, which is a medical product used for healthcare purposes. The award is not designated with a set-aside,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,390.00 firm fixed-price contract is for the supply of 4567321981 ! RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a medical product used for healthcare purposes. The contract has an ultimate completion date of March 13, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $2,775.00 to Amerisourcebergen Drug Corp, a for-profit pharmaceutical sourcing and distribution company. The contract is for the delivery of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML and has a performance period through March 20, 2024. This award is issued under Amerisourcebergen Drug Corp's single award indefinite delivery contract with DLA, valued at up to $999,999,999.00 through December...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,836.04 firm fixed price contract is for the supply of RHOPHYLAC, a 300 mcg/2 mL syringe medication, with an ultimate completion date of October 15, 2024. The award does not utilize a set-aside designation. AmerisourceBergen holds multiple Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, collectively valued up to...
This federal contract award is for the delivery of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $2,295.05 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 26, 2024, with a completion date of August 16, 2024. The contract is not designated with a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution and supply company, for the provision of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML. The contract has a potential value of $2,754.06 and a completion date of March 22, 2024. This award is not associated with any set-aside programs. Amerisourcebergen Drug Corp, through its Corporate Office division, has received numerous federal contracts from DLA...
This federal contract award is for the pharmaceutical product RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, awarded to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,377.03 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency that provides logistics and technical services to the U.S. Armed Forces and other government entities. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the federal government,...